Status and phase
Conditions
Treatments
About
The purpose of this study is to explore the possible cognitive effects of darifenacin modified release and long-acting oxybutynin.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Other protocol defined inclusion/exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
150 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal